Biotech vs. Shorts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (10)	7/25/1999 3:22:00 PM
From: LLCF	of 427

Business Week this week has Sturart Weisbrod of "Merlin Biomed" saying in the first paragraph "Although biotech stocks show signs of rebounding, they're still no picknic, "I'm short a lot of them" says Weisbrod. He goes on to say how he still believes that the best investment plays are in the "orphan" and undiscovered biotechs. The best catches he says can be snared amoung biotechs with market caps of about 100 million with promising product pipelines and ample cash. [likes ARNX, BRCX] The only short he listed was ENMD... it certainly wasn't a bash article... more like "it's dangerous out here, so you better hire me". DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next